BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23885028)

  • 1. A suppressor of cytokine signaling 1 antagonist enhances antigen-presenting capacity and tumor cell antigen-specific cytotoxic T lymphocyte responses by human monocyte-derived dendritic cells.
    Wang Y; Wang S; Ding Y; Ye Y; Xu Y; He H; Li Q; Mi Y; Guo C; Lin Z; Liu T; Zhang Y; Chen Y; Yan J
    Clin Vaccine Immunol; 2013 Sep; 20(9):1449-56. PubMed ID: 23885028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor effects and mechanisms of a dendritic cell vaccine which silenced SOCS1 by siRNA, stimulated by OK-432 and pulsed with lysate of HepG2 cells].
    Song HF; Zhou J; Pan K; Wang QJ; Wang H; Huang LX; Li YQ; Xia JC
    Ai Zheng; 2008 Jul; 27(7):685-91. PubMed ID: 18606059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitro.
    Shi D; Li D; Yin Q; Qiu Y; Yan H; Shen Y; Lu G; Liu W
    Immunol Res; 2015 Mar; 61(3):206-18. PubMed ID: 25381480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human suppressor of cytokine signaling 1 controls immunostimulatory activity of monocyte-derived dendritic cells.
    Hong B; Ren W; Song XT; Evel-Kabler K; Chen SY; Huang XF
    Cancer Res; 2009 Oct; 69(20):8076-84. PubMed ID: 19789342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lipid-soluble extract of Pinellia pedatisecta Schott orchestrates intratumoral dendritic cell-driven immune activation through SOCS1 signaling in cervical cancer.
    Wang Y; Lu C; Huang H; Yao S; Xu C; Ye Y; Gui S; Li G
    J Ethnopharmacol; 2021 Mar; 267():112837. PubMed ID: 32276009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of CML28-specific cytotoxic T cell responses using co-transfected dendritic cells with CML28 DNA vaccine and SOCS1 small interfering RNA expression vector.
    Zhou H; Zhang D; Wang Y; Dai M; Zhang L; Liu W; Liu D; Tan H; Huang Z
    Biochem Biophys Res Commun; 2006 Aug; 347(1):200-7. PubMed ID: 16815301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA.
    Subramanya S; Armant M; Salkowitz JR; Nyakeriga AM; Haridas V; Hasan M; Bansal A; Goepfert PA; Wynn KK; Ladell K; Price DA; N M; Kan-Mitchell J; Shankar P
    Mol Ther; 2010 Nov; 18(11):2028-37. PubMed ID: 20648001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells pulsed with gp96-peptide complexes derived from human hepatocellular carcinoma (HCC) induce specific cytotoxic T lymphocytes.
    Wang XH; Qin Y; Hu MH; Xie Y
    Cancer Immunol Immunother; 2005 Oct; 54(10):971-80. PubMed ID: 15965645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
    Strengell M; Lehtonen A; Matikainen S; Julkunen I
    J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
    Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of epidermal growth factor receptor fusion protein on the cytotoxic activity of SOCS1-silenced dendritic cells in vitro.
    Jiang Q; Wang X; Qian M; Chen D; Xu Y
    Oncol Rep; 2018 Mar; 39(3):1306-1312. PubMed ID: 29286121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
    Kalady MF; Onaitis MW; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
    J Surg Res; 2004 Jan; 116(1):24-31. PubMed ID: 14732346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling.
    Jackson SH; Yu CR; Mahdi RM; Ebong S; Egwuagu CE
    J Immunol; 2004 Feb; 172(4):2307-15. PubMed ID: 14764699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scrib and Dlg1 polarity proteins regulate Ag presentation in human dendritic cells.
    Barreda D; Ramón-Luing LA; Duran-Luis O; Bobadilla K; Chacón-Salinas R; Santos-Mendoza T
    J Leukoc Biol; 2020 Sep; 108(3):883-893. PubMed ID: 32293058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
    Heo MB; Cho MY; Lim YT
    Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Mar; 170(6):2912-22. PubMed ID: 12626542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells.
    Song XT; Evel-Kabler K; Rollins L; Aldrich M; Gao F; Huang XF; Chen SY
    PLoS Med; 2006 Jan; 3(1):e11. PubMed ID: 16381597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.
    Song S; Wang Y; Wang J; Lian W; Liu S; Zhang Z; Liu F; Wei L
    Eur J Cancer; 2012 Sep; 48(14):2252-9. PubMed ID: 22230748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.